Home Register

Demystifying Wound Care Excellence: Unlocking the Secrets to Transformational Healing

Thu, Oct 2, 2025 - Fri, Oct 3, 2025

You're Invited!

Demystifying Wound Care Excellence: Unlocking the Secrets to Transformational Healing

 

Join us for an unforgettable day of discovery, insight, and innovation at the MIMEDX 2025 Henderson Summit — a premier event designed to empower Healthcare Professionals with the latest clinical applications of human Placental-Based Allografts.

 

This exclusive summit will feature renowned clinicians and thought leaders who will share real-world case studies demonstrating how MIMEDX products have advanced patient outcomes across chronic and acute wound care, surgical repair, and non-surgical treatment strategies.

 

✨ Don’t miss a rare, live placental dissection led by Randall Spencer, VP of Clinical Innovations — a hands-on look into the science and power of placental tissue in action!

 

Whether you're seeking clinical education, inspiration from your peers, or the chance to be on the forefront of regenerative medicine, this is the event you won't want to miss.

 

--
days
--
hours
--
mins
--
secs

 

Randall Spencer

Randall Spencer, Vice President of Clinical Innovations Mr. Spencer is the co-founder of Surgical Biologics, a leading processor of amnion tissue for use in a variety of surgical implants. Since the founding of Surgical Biologics in 2006, he led the development of the proprietary PURION® process, which processes human amniotic membrane to produce a safe, effective and minimally manipulated implant for homologous use. He has been a pioneer in the development of the latest advances in processing amniotic membrane tissue. MIMEDX® acquired Surgical Biologics in January 2011, and Mr. Spencer currently serves as Vice President of Clinical Innovation

Kathleen Schaum

Kathleen has recently celebrated her 54th year of working in the medical reimbursement arena. As the founder and president of her own consulting company, Kathleen D. Schaum & Associates, Inc. she shares her 50+ years of knowledge and experience with wound/ulcer management stakeholders.

John Harper

Dr. John Harper joined MIMEDX as Chief Science Officer and Senior Vice President of Research and Product Development in June 2021. Dr. Harper has over 40 peer-reviewed publications and his principal areas of research interest are extracellular matrix biochemistry, tissue regeneration, and wound healing. He received his Ph.D. in Biomedical Sciences from The University of Texas, M.D. Anderson Cancer Center in Houston and completed post-doctoral fellowships in cancer biochemistry and cell biology at Scripps Clinic in La Jolla, California and the National Cancer Institute in Bethesda, Maryland.

Dr. Harper serves on the Board of Directors of Kent Imaging, Nanomedic Technologies, and the American College of Wound Healing and Tissue Repair.